TNYA - Tenaya Therapeutics GAAP EPS of -$0.61 beats by $0.03
2023-03-08 18:08:57 ET
- Tenaya Therapeutics press release ( NASDAQ: TNYA ): Q4 GAAP EPS of -$0.61 beats by $0.03 .
- As of December 31, 2022, cash, cash equivalents and investments in marketable securities (current and noncurrent) were $204.2 million. Tenaya expects current cash, cash equivalents and investments in marketable securities (current and noncurrent) will be sufficient to fund the company into the first half of 2025.
For further details see:
Tenaya Therapeutics GAAP EPS of -$0.61 beats by $0.03